Immunosuppression with mycophenolate mofetil attenuates the development of hypertension and albuminuria in deoxycorticosterone acetate-salt hypertensive rats

被引:37
|
作者
Boesen, Erika I. [1 ]
Williams, Douglas L. [1 ]
Pollock, Jennifer S. [1 ]
Pollock, David M. [1 ]
机构
[1] Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA
基金
美国国家卫生研究院;
关键词
hypertension; kidney; macrophage; mineralocorticoid; T-lymphocyte; IMMUNE CELL INFILTRATION; ANGIOTENSIN-II; SENSITIVE HYPERTENSION; BLOOD-PRESSURE; RENAL DAMAGE; MINERALOCORTICOID RECEPTORS; ARTERIAL-PRESSURE; OXIDATIVE STRESS; T-CELL; KIDNEY;
D O I
10.1111/j.1440-1681.2010.05428.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
P>1. The interplay between the immune and renin-angiotensin systems is emerging as a crucial factor in the development and progression of hypertension. The aim of the present study was to determine the involvement of immune cells in the hypertension and renal injury produced by a non-angiotensin II-dependent form of hypertension, namely deoxycorticosterone acetate (DOCA)-salt-induced hypertension, in rats. 2. Male Sprague-Dawley rats underwent uninephrectomy and received either a sustained-release pellet of DOCA s.c. and 0.9% NaCl (saline) to drink for 21 days or a placebo pellet and water to drink for 21 days. Additional groups of DOCA-salt- and placebo-treated rats were treated concurrently with the immune suppressant mycophenolate mofetil (MMF; 30 mg/kg per day). Rats were placed in metabolic cages for 24 h urine collection prior to and at weekly intervals during the 21 day experimental period. 3. Mycophenolate mofetil significantly attenuated the development of hypertension in DOCA-salt rats compared with untreated DOCA-salt hypertensive rats (mean arterial pressure by telemetry on Day 18 146 +/- 7 vs 180 +/- 3 mmHg, respectively; P < 0.001), as well as proteinuria (87 +/- 27 vs 305 +/- 63 mg/day, respectively, on Day 21) and albuminuria (51 +/- 15 vs 247 +/- 73 mg/day, respectively, on Day 21). Creatinine clearance was better preserved in MMF-treated DOCA-salt rats compared with untreated DOCA-salt rats (0.74 +/- 0.07 vs 0.49 +/- 0.09 mL/min, respectively; P < 0.05), but was still significantly reduced compared with that in the placebo group (1.15 +/- 0.12 mL/min; P < 0.05). Finally, MMF treatment significantly attenuated the DOCA-salt-induced rise in renal cortical T-lymphocyte and macrophage infiltration (P < 0.05). 4. These data indicate that immune cells play a deleterious role in both the hypertension and renal injury associated with DOCA-salt hypertension.
引用
收藏
页码:1016 / 1022
页数:7
相关论文
共 50 条
  • [31] Cortical and medullary hemodynamics in deoxycorticosterone acetate-salt hypertensive mice
    Gross, V
    Lippoldt, A
    Bohlender, J
    Bader, M
    Hansson, A
    Luft, FC
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1998, 9 (03): : 346 - 354
  • [32] Effect of Scurrula atropurpurea on blood pressure and angiotensin Ⅱ of deoxycorticosterone acetate-salt hypertensive rats
    Setyawati SOEHARTO
    Nour ATHIROH
    中国药理学与毒理学杂志, 2015, 29(S1) (S1) : 37 - 37
  • [33] Effects of the endothelin ET(A)-receptor antagonist FR139317 on development of hypertension and cardiovascular hypertrophy in deoxycorticosterone acetate-salt hypertensive rats
    Fujita, K
    Matsumura, Y
    Miyazaki, Y
    Takaoka, M
    Morimoto, S
    JAPANESE JOURNAL OF PHARMACOLOGY, 1996, 70 (04): : 313 - 319
  • [34] Sympathetic Nerve Activity during Development of Deoxycorticosterone Acetate-Salt Hypertension in Rat
    Yoshimoto, Misa
    Shiwa, Yuki
    Setoguchi, Shiori
    Kawamura, Shiho
    Miki, Kenju
    FASEB JOURNAL, 2017, 31
  • [35] Estrogen Metabolite 2-methoxyestradiol Prevents Hypertension in Deoxycorticosterone Acetate-salt Rats
    Wensu Yuan
    Yueyi Yu
    Jingjing Li
    Pavneet Singh
    Dong Li
    Yu Gui
    Xi-Long Zheng
    Cardiovascular Drugs and Therapy, 2013, 27 : 17 - 22
  • [37] Estrogen Metabolite 2-methoxyestradiol Prevents Hypertension in Deoxycorticosterone Acetate-salt Rats
    Yuan, Wensu
    Yu, Yueyi
    Li, Jingjing
    Singh, Pavneet
    Li, Dong
    Gui, Yu
    Zheng, Xi-Long
    CARDIOVASCULAR DRUGS AND THERAPY, 2013, 27 (01) : 17 - 22
  • [38] Intracerebroventricular Administration of Autologous Bone Marrow-derived Cells Attenuates Sympathetic Hyperactivity in Deoxycorticosterone Acetate-salt Hypertensive Rats
    Yamazato, Masanobu
    Nakamura, Takuto
    Ishida, Akio
    Yamazato, Yoriko
    Ohya, Yusuke
    HYPERTENSION, 2013, 62 (03)
  • [39] Effects of sesamin on aortic oxidative stress and endothelial dysfunction in deoxycorticosterone acetate-salt hypertensive rats
    Nakano, D
    Itoh, C
    Ishii, F
    Kawanishi, H
    Takaoka, M
    Kiso, Y
    Tsuruoka, N
    Tanaka, T
    Matsumura, Y
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2003, 26 (12) : 1701 - 1705
  • [40] P2X7 deficiency attenuates hypertension and renal injury in deoxycorticosterone acetate-salt hypertension
    Ji, Xu
    Naito, Yukiko
    Weng, Huachun
    Endo, Kosuke
    Ma, Xiao
    Iwai, Naoharu
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2012, 303 (08) : F1207 - F1215